Clinical Trial Update: Measuring Non-Enhancing Glioblastoma Progression

View source ↗

Summary

A completed clinical trial update describing methods for measuring progression in non-enhancing glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Tumor, Glioblastoma | Status: COMPLETED